This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Mental Health Gender Gap: Women Far Exceed Men In Their Use Of Psychotropic Medications As Utilization Increases Among Both Sexes

Stocks in this article: MHS





WASHINGTON, March 19, 2012 /PRNewswire/ -- Women far outpace their male counterparts when it comes to the consumption of mental health medications, with 25 percent using at least one psychotropic drug as compared to 15 percent of men.  These are findings from research by Medco Health Solutions, Inc. (NYSE: MHS) that were presented Saturday at the 2012 Women's Health Congress.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO )

The study reviewed the pharmacy claims of more than two million insured Americans and assessed the use of antidepressants, antipsychotics, anti-anxiety medications and drugs to treat attention deficit hyperactivity disorder (ADHD) between 2001 and 2010. 

"Some mental health medications such as antidepressants have historically been more widely used by women than men," said lead researcher, Dr. David Muzina, a psychiatrist and national practice leader of the Medco Neuroscience Therapeutic Resource Center®.   "However, what is surprising is how many women are taking these medications and the substantial increase in the number of women on treatments that have traditionally not been heavily used by females, like ADHD drugs." 

The research shows that antidepressants are by far the most commonly utilized psychotropic medication, with 21 percent of women on one of these drugs in 2010.  Both men and women's use increased about 29 percent from the start of the decade, but the number of men taking antidepressants remained about half that of women at 11 percent.

Women also trump men in utilization of anti-anxiety medications. Eleven percent of women ages 45-64 were on an anti-anxiety medication – nearly twice the rate (5.7 percent) of their male counterparts.

While far more boys than girls take ADHD medications, a higher number of women than men are utilizing them as adults.  Females aged 20-44 had the highest use among adults as their utilization rose a staggering 264 percent over the decade, as compared to a 188 percent increase for males the same age.   

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs